Are you Dr. Nottage?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 15 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
262 Danny Thomas Pl
Memphis, TN 38105Phone+1 901-595-6216Fax+1 901-595-2952- Is this information wrong?
Summary
- Dr. Kerri Nottage, MD is a pediatric hematologist/oncologist in Memphis, Tennessee. She is currently licensed to practice medicine in Tennessee and New Jersey. She is affiliated with Le Bonheur Children's Hospital.
Education & Training
Brown UniversityResidency, Internal Medicine/Pediatrics, 2004 - 2008
The Warren Alpert Medical School of Brown UniversityClass of 2004
Certifications & Licensure
NJ State Medical License 2016 - 2023
TN State Medical License 2009 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease Start of enrollment: 2006 Mar 03
- Transfusional Iron Overload Among Leukemia Survivors Start of enrollment: 2013 Oct 18
Publications & Presentations
PubMed
- 1 citationsCusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose opti...Thomas Pabst, Cristina Papayannidis, Fatih Demirkan, Vadim Doronin, Laura M Fogliatto, Christina Guttke, Emmanuel Gyan, Nada Hamad, Pilar Herrera, Anna Hultberg, Julie...> ;The Lancet. Haematology. 2023 Nov 1
- 4 citationsIbrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial.G A Amos Burke, Luciana Vinti, Edita Kabickova, Auke Beishuizen, Nurdan Tacyildiz, Anne Uyttebroeck, Hyoung Jin Kang, Flavio Luisi, Véronique Minard-Colin, Birgit Burk...> ;Blood Advances. 2023 Feb 28
- 10 citationsResults from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemo...Thomas Pabst, Norbert Vey, Lionel Adès, Ulrike Bacher, Mario Bargetzi, Samson Fung, Gianluca Gaidano, Domenica Gandini, Anna Hultberg, Amy Johnson, Xuewen Ma, Rouven M...> ;Haematologica. 2023 Jul 1
- Join now to see all
Hospital Affiliations
- Le Bonheur Children's HospitalMemphis, Tennessee
